Breakthrough Treatment for Large B-Cell Lymphoma

The FDA approved CAR T cell therapy, which harnesses the patient’s own immune system to fight cancer.

A cell-based gene therapy, Yescarta (axicabtagene ciloleucel), was approved by the Food and Drug Administration in October 2017 to treat adults with certain kinds of large B-cell lymphoma who have not responded to other kinds of treatment. It is the first gene therapy approved for certain types of non-Hodgkin lymphoma, a cancer of the blood […]

Tags , , , , , , , , , , , , , , , , , , , , , , , , ,
Comments

Leave a Reply

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×